Literature DB >> 15665709

Clinical features and genotyping analysis of community-acquired methicillin-resistant Staphylococcus aureus infections in Taiwanese children.

Chih-Jung Chen1, Yhu-Chering Huang, Cheng-Hsun Chiu, Lin-Hui Su, Tzou-Yien Lin.   

Abstract

BACKGROUND: Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) infection in children without health care-associated risk factors has emerged. To evaluate the clinical features and genotyping analysis of CA-MRSA in children in Taiwan, we conducted this study.
METHODS: Between July 2000 and June 2001, 198 episodes of S. aureus infection were identified in 191 children hospitalized at Chang-Gung Children's Hospital. The medical records of these children were retrospectively reviewed. The MRSA clinical isolates from each episode of infection, if available, were collected for pulsed-field gel electrophoresis (PFGE) typing and staphylococcal cassette chromosome mec (SCCmec) type determination.
RESULTS: Among the 198 episodes of S. aureus infection, MRSA accounted for 47% of 114 CA infections and 62% of 84 hospital-acquired (HA) infections, respectively. Among 54 CA-MRSA infections, 32 episodes (59%) occurred in children without risk factors. Similar to HA-MRSA isolates, these CA-MRSA isolates were also multiresistant, with a high rate of resistance to clindamycin (93%) and erythromycin (94%), but 91% of them were susceptible to trimethoprim/sulfamethoxazole. Superficial soft tissue infection was the most common presentation, accounting for 65% of CA-MRSA infections. All 54 children with CA-MRSA infection recovered without sequelae, though 63% of 35 children with superficial soft tissue infection were treated with in vitro nonsusceptible antibiotics. Of the 83 clinical isolates (40 CA, 22 with no identified risk) available for analysis, 6 genotypes with 30 subtypes were identified. Three major PFGE patterns were identified, accounting for 94% of the isolates (92.5% for CA isolates, 95% for HA isolates). Type IV SCCmec was carried by 25 and 40% of CA and HA isolates, respectively.
CONCLUSION: In Taiwan, MRSA was prevalent among pathogens of CA infections in children, and these CA isolates were multiresistant and genetically associated with HA isolates. In an area with a high prevalence of methicillin resistance, for children with putative S. aureus infection, even community-acquired, a glycopeptide-containing regimen should be considered for initial empirical therapy in the case of serious infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15665709     DOI: 10.1097/01.inf.0000148926.11227.1c

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  20 in total

1.  Changing molecular epidemiology of methicillin-resistant Staphylococcus aureus bloodstream isolates from a teaching hospital in Northern Taiwan.

Authors:  Yhu-Chering Huang; Lin-Hui Su; Tsu-Lan Wu; Tzou-Yien Lin
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

2.  A nosocomial outbreak of community-associated methicillin-resistant Staphylococcus aureus among healthy newborns and postpartum mothers.

Authors:  Andrea Saunders; Linda Panaro; Allison McGeer; Alana Rosenthal; Diane White; Barbara M Willey; Denise Gravel; Erika Bontovics; Barbara Yaffe; Kevin Katz
Journal:  Can J Infect Dis Med Microbiol       Date:  2007-03       Impact factor: 2.471

3.  Guidelines for the prevention and management of community-associated methicillin-resistant Staphylococcus aureus: A perspective for Canadian health care practitioners.

Authors:  Michelle Barton; Michael Hawkes; Dorothy Moore; John Conly; Lindsay Nicolle; Upton Allen; Nora Boyd; Joanne Embree; Liz Van Horne; Nicole Le Saux; Susan Richardson; Aideen Moore; Dat Tran; Valerie Waters; Mary Vearncombe; Kevin Katz; J Scott Weese; John Embil; Marianna Ofner-Agostini; E Lee Ford-Jones
Journal:  Can J Infect Dis Med Microbiol       Date:  2006-09       Impact factor: 2.471

4.  Clindamycin versus trimethoprim-sulfamethoxazole for uncomplicated skin infections.

Authors:  Loren G Miller; Robert S Daum; C Buddy Creech; David Young; Michele D Downing; Samantha J Eells; Stephanie Pettibone; Rebecca J Hoagland; Henry F Chambers
Journal:  N Engl J Med       Date:  2015-03-19       Impact factor: 91.245

5.  Carriage of community-associated methicillin-resistant Staphylococcus aureus in a cohort of infants in southern Israel: risk factors and molecular features.

Authors:  Amos Adler; Noga Givon-Lavi; Allon E Moses; Colin Block; Ron Dagan
Journal:  J Clin Microbiol       Date:  2009-12-09       Impact factor: 5.948

6.  Unusually high prevalence of panton-valentine leukocidin genes among methicillin-sensitive Staphylococcus aureus strains carried in the Indonesian population.

Authors:  Juliëtte A Severin; Endang Sri Lestari; Kuntaman Kuntaman; Damian C Melles; Martijn Pastink; Justine K Peeters; Susan V Snijders; Usman Hadi; D Offra Duerink; Alex van Belkum; Henri A Verbrugh
Journal:  J Clin Microbiol       Date:  2008-04-23       Impact factor: 5.948

7.  Prevalence of methicillin-resistant Staphylococcus aureus nasal colonization among Taiwanese children in 2005 and 2006.

Authors:  Yhu-Chering Huang; Kao-Pin Hwang; Po-Yen Chen; Chih-Jung Chen; Tzou-Yien Lin
Journal:  J Clin Microbiol       Date:  2007-10-17       Impact factor: 5.948

8.  Changes in the nasal colonization with methicillin-resistant Staphylococcus aureus in children: 2004-2009.

Authors:  Wen-Tsung Lo; Chih-Chien Wang; Wei-Jen Lin; Sheng-Ru Wang; Ching-Shen Teng; Ching-Feng Huang; Shyi-Jou Chen
Journal:  PLoS One       Date:  2010-12-29       Impact factor: 3.240

9.  Retrospective study of necrotizing fasciitis and characterization of its associated methicillin-resistant Staphylococcus aureus in Taiwan.

Authors:  Chih-Hsuan Changchien; Ying-Ying Chen; Shu-Wun Chen; Wan-Lin Chen; Jwu-Guh Tsay; Chishih Chu
Journal:  BMC Infect Dis       Date:  2011-10-31       Impact factor: 3.090

10.  Methicillin-resistant Staphylococcus aureus skin infections.

Authors:  Jui-Shan Ma
Journal:  Emerg Infect Dis       Date:  2005-10       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.